{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:22:57Z","timestamp":1784071377547,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11255-020-02469-z","type":"journal-article","created":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T14:05:21Z","timestamp":1587391521000},"page":"1125-1133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4396-5032","authenticated-orcid":false,"given":"Valeria","family":"Cernaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Loddo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Macaione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Teresa","family":"Ferlazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia Maria","family":"Cigala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina Rita Rosalia","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Gembillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Bolignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Buemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Benvenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"issue":"5","key":"2469_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3109\/0886022X.2015.1015683","volume":"37","author":"V Cernaro","year":"2015","unstructured":"Cernaro V, Medici MA, Leonello G et al (2015) Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells. Ren Fail 37(5):911\u2013913","journal-title":"Ren Fail"},{"key":"2469_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cca.2017.02.008","volume":"468","author":"KP Law","year":"2017","unstructured":"Law KP, Zhang H (2017) The pathogenesis and pathophysiology of gestational diabetes mellitus: deductions from a three-part longitudinal metabolomics study in China. Clin Chim Acta 468:60\u201370","journal-title":"Clin Chim Acta"},{"issue":"7","key":"2469_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ et al (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13(7):465\u2013477","journal-title":"Nat Rev Neurosci"},{"key":"2469_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1196\/annals.1403.003","volume":"1122","author":"GF Oxenkrug","year":"2007","unstructured":"Oxenkrug GF (2007) Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging. Ann N Y Acad Sci 1122:35\u201349","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"2469_CR5","doi-asserted-by":"publisher","first-page":"e0196404","DOI":"10.1371\/journal.pone.0196404","volume":"13","author":"GS Jayawickrama","year":"2018","unstructured":"Jayawickrama GS, Nematollahi A, Sun G et al (2018) Improvement of kynurenine aminotransferase-II inhibitors guided by mimicking sulfate esters. PLoS ONE 13(4):e0196404","journal-title":"PLoS ONE"},{"issue":"11 Pt A","key":"2469_CR6","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.bbagen.2016.07.002","volume":"1860","author":"PB Larkin","year":"2016","unstructured":"Larkin PB, Sathyasaikumar KV, Notarangelo FM et al (2016) Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice. Biochim Biophys Acta 1860(11 Pt A):2345\u20132354","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2469_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12035-013-8497-4","volume":"48","author":"G Oxenkrug","year":"2013","unstructured":"Oxenkrug G (2013) Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways. Mol Neurobiol 48(2):294\u2013301","journal-title":"Mol Neurobiol"},{"key":"2469_CR8","doi-asserted-by":"publisher","first-page":"117864691769460","DOI":"10.1177\/1178646917694600","volume":"10","author":"S Debnath","year":"2017","unstructured":"Debnath S, Velagapudi C, Redus L et al (2017) Tryptophan metabolism in patients with chronic kidney disease secondary to type 2 diabetes: relationship to inflammatory markers. Int J Tryptophan Res 10:1178646917694600","journal-title":"Int J Tryptophan Res"},{"issue":"6","key":"2469_CR9","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/ndt\/gfn739","volume":"24","author":"JC Schefold","year":"2009","unstructured":"Schefold JC, Zeden JP, Fotopoulou C et al (2009) Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms. Nephrol Dial Transplant 24(6):1901\u20131908","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"2469_CR10","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","volume":"63","author":"R Vanholder","year":"2003","unstructured":"Vanholder R, De Smet R, Glorieux G et al (2003) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63(5):1934\u20131943","journal-title":"Kidney Int"},{"issue":"11","key":"2469_CR11","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1681\/ASN.2015070835","volume":"27","author":"R Korstanje","year":"2016","unstructured":"Korstanje R, Deutsch K, Bolanos-Palmieri P et al (2016) Loss of kynurenine 3-mono-oxygenase causes proteinuria. J Am Soc Nephrol 27(11):3271\u20133277","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"2469_CR12","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s00216-012-6412-x","volume":"404","author":"A Hirayama","year":"2012","unstructured":"Hirayama A, Nakashima E, Sugimoto M et al (2012) Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy. Anal Bioanal Chem 404(10):3101\u20133109","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"2469_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Group KDIGOKCW","year":"2013","unstructured":"Group KDIGOKCW (2013) KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):1\u2013150","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"2469_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"issue":"1","key":"2469_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jdiacomp.2016.08.020","volume":"31","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Ruan Y, Zhang P et al (2017) Increased indoleamine 2,3-dioxygenase activity in type 2 diabetic nephropathy. J Diabetes Complicat 31(1):223\u2013227","journal-title":"J Diabetes Complicat"},{"issue":"8 Suppl B","key":"2469_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.18553\/jmcp.2007.13.s8-b.9","volume":"13","author":"SA Atlas","year":"2007","unstructured":"Atlas SA (2007) The renin\u2013angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm. 13(8 Suppl B):9\u201320","journal-title":"J Manag Care Pharm."},{"key":"2469_CR17","doi-asserted-by":"publisher","first-page":"689360","DOI":"10.1155\/2014\/689360","volume":"2014","author":"M Pacurari","year":"2014","unstructured":"Pacurari M, Kafoury R, Tchounwou PB et al (2014) The Renin\u2013Angiotensin\u2013aldosterone system in vascular inflammation and remodeling. Int J Inflam 2014:689360","journal-title":"Int J Inflam"},{"issue":"4","key":"2469_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1254\/jphs.10R03FM","volume":"113","author":"A Nishiyama","year":"2010","unstructured":"Nishiyama A, Kim-Mitsuyama S (2010) New approaches to blockade of the renin-angiotensin-aldosterone system: overview of regulation of the renin\u2013angiotensin-aldosterone system. J Pharmacol Sci 113(4):289\u2013291","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"2469_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrneph.2013.251","volume":"10","author":"SS Roscioni","year":"2014","unstructured":"Roscioni SS, Heerspink HJ, de Zeeuw D (2014) The effect of RAAS blockade on the progression of diabetic nephropathy. Nat Rev Nephrol 10(2):77\u201387","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"2469_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1517\/13543784.2014.899352","volume":"23","author":"V Cernaro","year":"2014","unstructured":"Cernaro V, Trifir\u00f2 G, Lorenzano G et al (2014) New therapeutic strategies under development to halt the progression of renal failure. Expert Opin Investig Drugs 23(5):693\u2013709","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"2469_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/MNH.0000000000000214","volume":"25","author":"Y Lytvyn","year":"2016","unstructured":"Lytvyn Y, Bjornstad P, Pun N et al (2016) New and old agents in the management of diabetic nephropathy. Curr Opin Nephrol Hypertens 25(3):232\u2013239","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"2469_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/toxins10060226","volume":"10","author":"RD Mair","year":"2018","unstructured":"Mair RD, Sirich TL, Meyer TW (2018) Uremic toxin clearance and cardiovascular toxicities. Toxins (Basel) 10(6):226","journal-title":"Toxins (Basel)"},{"issue":"7","key":"2469_CR23","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1177\/1535370217693114","volume":"242","author":"J Bartosiewicz","year":"2017","unstructured":"Bartosiewicz J, Kaminski T, Pawlak K et al (2017) The activation of the kynurenine pathway in a rat model with renovascular hypertension. Exp Biol Med (Maywood) 242(7):750\u2013761","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"2469_CR24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.pharep.2017.01.023","volume":"69","author":"I Zakrocka","year":"2017","unstructured":"Zakrocka I, Kocki T, Turski WA (2017) The effect of three angiotensin-converting enzyme inhibitors on kynurenic acid production in rat kidney in vitro. Pharmacol Rep 69(3):536\u2013541","journal-title":"Pharmacol Rep"},{"issue":"2","key":"2469_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00210-018-1572-7","volume":"392","author":"I Zakrocka","year":"2019","unstructured":"Zakrocka I, Targowska-Duda KM, Wnorowski A et al (2019) Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro. Naunyn Schmiedebergs Arch Pharmacol 392(2):209\u2013217","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"12","key":"2469_CR26","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1093\/clinchem\/43.12.2424","volume":"43","author":"B Widner","year":"1997","unstructured":"Widner B, Werner ER, Schennach H et al (1997) Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 43(12):2424\u20132426","journal-title":"Clin Chem"},{"key":"2469_CR27","first-page":"31","volume":"9","author":"AA Badawy","year":"2016","unstructured":"Badawy AA, Dougherty DM (2016) Assessment of the human kynurenine pathway: comparisons and clinical implications of ethnic and gender differences in plasma tryptophan, kynurenine metabolites, and enzyme expressions at baseline and after acute tryptophan loading and depletion. Int J Tryptophan Res 9:31\u201349","journal-title":"Int J Tryptophan Res"},{"issue":"1","key":"2469_CR28","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1038\/s41598-018-25288-w","volume":"8","author":"AM Baratta","year":"2018","unstructured":"Baratta AM, Buck SA, Buchla AD et al (2018) Sex differences in hippocampal memory and kynurenic acid formation following acute sleep deprivation in rats. Sci Rep 8(1):6963","journal-title":"Sci Rep"},{"issue":"12","key":"2469_CR29","doi-asserted-by":"publisher","first-page":"e82279","DOI":"10.1371\/journal.pone.0082279","volume":"8","author":"V Chauvel","year":"2013","unstructured":"Chauvel V, Schoenen J, Multon S (2013) Influence of ovarian hormones on cortical spreading depression and its suppression by l-kynurenine in rat. PLoS ONE 8(12):e82279","journal-title":"PLoS ONE"},{"key":"2469_CR30","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3389\/fphar.2019.01044","volume":"10","author":"E Fertan","year":"2019","unstructured":"Fertan E, Stover KRJ, Brant MG et al (2019) Effects of the novel IDO inhibitor DWG-1036 on the behavior of male and female 3xTg-AD mice. Front Pharmacol 10:1044","journal-title":"Front Pharmacol"},{"key":"2469_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbi.2017.08.024","volume":"67","author":"TB Meier","year":"2018","unstructured":"Meier TB, Drevets WC, Teague TK et al (2018) Kynurenic acid is reduced in females and oral contraceptive users: Implications for depression. Brain Behav Immun 67:59\u201364","journal-title":"Brain Behav Immun"},{"key":"2469_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fpsyt.2019.00074","volume":"10","author":"EZ Reininghaus","year":"2019","unstructured":"Reininghaus EZ, Dalkner N, Riedrich K et al (2019) Sex specific changes in tryptophan breakdown over a 6 week treatment period. Front Psychiatry 10:74","journal-title":"Front Psychiatry"},{"issue":"19","key":"2469_CR33","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.2174\/1568026618666181115093136","volume":"18","author":"T Songtachalert","year":"2018","unstructured":"Songtachalert T, Roomruangwong C, Carvalho AF et al (2018) Anxiety disorders: sex differences in serotonin and tryptophan metabolism. Curr Top Med Chem 18(19):1704\u20131715","journal-title":"Curr Top Med Chem"},{"issue":"10","key":"2469_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/metabo9100212","volume":"9","author":"S Naz","year":"2019","unstructured":"Naz S, Bhat M, Stahl S et al (2019) Dysregulation of the tryptophan pathway evidences gender differences in COPD. Metabolites 9(10):212","journal-title":"Metabolites"},{"issue":"1","key":"2469_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/molecules23010191","volume":"23","author":"K Sas","year":"2018","unstructured":"Sas K, Szabo E, Vecsei L (2018) Mitochondria, oxidative stress and the kynurenine system, with a focus on ageing and neuroprotection. Molecules 23(1):191","journal-title":"Molecules"},{"key":"2469_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2009.05356.x","volume":"1199","author":"GF Oxenkrug","year":"2010","unstructured":"Oxenkrug GF (2010) Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Ann N Y Acad Sci 1199:1\u201314","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2469_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2008.08.014","volume":"204","author":"K Pawlak","year":"2009","unstructured":"Pawlak K, Domaniewski T, Mysliwiec M et al (2009) The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. Atherosclerosis 204(1):309\u2013314","journal-title":"Atherosclerosis"},{"key":"2469_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biochi.2018.06.009","volume":"152","author":"RE Silva","year":"2018","unstructured":"Silva RE, Baldim JL, Chagas-Paula DA et al (2018) Predictive metabolomic signatures of end-stage renal disease: a multivariate analysis of population-based data. Biochimie 152:14\u201330","journal-title":"Biochimie"},{"key":"2469_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jprot.2018.09.020","volume":"193","author":"M Canadas-Garre","year":"2019","unstructured":"Canadas-Garre M, Anderson K, McGoldrick J et al (2019) Proteomic and metabolomic approaches in the search for biomarkers in chronic kidney disease. J Proteomics 193:93\u2013122","journal-title":"J Proteomics"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02469-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-020-02469-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02469-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:32:18Z","timestamp":1618878738000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-020-02469-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2469"],"URL":"https:\/\/doi.org\/10.1007\/s11255-020-02469-z","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]},"assertion":[{"value":"20 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"There is no research involving human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"Written informed consent was obtained from all recruited patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}